Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • rehdvm2004 rehdvm2004 Jul 31, 2013 10:06 AM Flag

    Hopeful that . . .

    Arikace clinical trial data will be submitted in the US . . . otherwise people will be going to Canada to get the prescription; and

    There are less than 10 more NTM patients to be enrolled. Last CC it was 81 enrolled which was about a month ago. This clinical trial should be getting momentum with all 19 (?) clinical sites recruiting. The review by FDA should be expedited because it will be NIH QA/QC.

    Longs . . . keep your fingers crossed.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • by rehdvm2004 • Jul 31, 2013 10:06 AM Flag
      Arikace clinical trial data will be submitted in the US . . . otherwise people will be going to Canada to get the prescription; and

      There are less than 10 more NTM patients to be enrolled. Last CC it was 81 enrolled which was about a month ago. This clinical trial should be getting momentum with all 19 (?) clinical sites recruiting. The review by FDA should be expedited because it will be NIH QA/QC.

      Longs . . . keep your fingers crossed.

    • Most CF patients that need prescriptions can not pay for the high price of the drugs. Arikace pricing will be higher than others."going to Canada " is not covered by Medicare.Unless the drug is approved by the FDA, Arikace will see little if any Arikace revenues with the CF population

    • They are beginning to hurt after being crossed 6 years now.

 
INSM
9.88+0.16(+1.65%)Jun 29 4:00 PMEDT